🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
This phase II trial studies how well combination chemotherapy works in trea...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-10-19
Trial ID
NCT04322318
Treatments Being Tested
This phase I trial tests the safety and side effects of B-cell activating f...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-04-17
Trial ID
NCT07758673
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
This phase II clinical trial evaluates whether a modified modality of condi...
Status
Recruiting
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2021-10-25
Trial ID
NCT05031897
The goal of this observational study is to establish a prospective cohort o...
Status
Recruiting
Location
Changhai Hospital
Start Date
2025-04-13
Trial ID
NCT06925204
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This randomized phase III trial studies combination chemotherapy with blina...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-05-19
Trial ID
NCT02003222
Treatments Being Tested